Enovis (ENOV) Return on Capital Employed Growth (3y) (2014 - 2026)
Enovis (ENOV) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | -846.00 |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 1,318.00 |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | -247.00 |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | - |
| 10 | Enovis | 1.59 Bn | 1.56 Bn | 365.49 Mn | -3,154.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -3,154.00 |
| Dec 31, 2025 | -2,992.00 |
| Oct 3, 2025 | -2,930.00 |
| Jul 4, 2025 | -1,481.00 |
| Apr 4, 2025 | -1,620.00 |
| Dec 31, 2024 | -1,707.00 |
| Sep 27, 2024 | -36.00 |
| Jun 28, 2024 | -131.00 |
| Mar 29, 2024 | -86.00 |
| Dec 31, 2023 | -58.00 |
| Sep 29, 2023 | -525.00 |
| Jun 30, 2023 | -522.00 |
| Mar 31, 2023 | -542.00 |
| Dec 31, 2022 | -454.00 |
| Sep 30, 2022 | -337.00 |
| Jul 1, 2022 | -377.00 |
| Apr 1, 2022 | -360.00 |
| Dec 31, 2021 | -295.00 |
| Oct 1, 2021 | -335.00 |
| Dec 31, 2020 | -342.00 |